New Paragraph IV Patent Certifications reported by USFDA till May 19, 2009

1) Abacavir Sulfate 300 mg Tablets (Ziagen) Para IV filed on Jan 28, 2009

2) Cevimeline Hydrochloride 30 mg Capsules (Evoxac) Para IV filed on Feb 27, 2009

3) Conjugated Estrogen (Synthetic A) 0.625 mgTablets (Cenestin) Para IV filed on March 2, 2009

4) Dextromethorphan Polistirex 30 mg/5 mL Extended-release Suspension (Delsym) Para IV filed on Jan 12, 2009

5) Doxycycline 40 mg Delayed-release Capsules (Oracea) Para IV filed on Dec 11, 2008

6) Formoterol Fumarate 0.02 mg/2 mL Inhalation Solution (Perforomist) Para IV filed on Jan 21, 2009

7) Ropinirole Hydrochloride Extended-release Tablets (Requip XL)3 mg Para IV filed on Jan 8, 2009 and 12 mg on Feb 5, 2009

8) Levocetirizine Dihydrochloride 0.5 mg/mL Oral Solution (Xyzal) Para IV filed on Jan 14, 2009 (Probably, Synthon is the only ANDA filer for this product as per press release from Synthon Here )

9) Travoprost (Preserved) 0.004% Ophthalmic Solution (Travatan Z) Para IV filed on Feb 19, 2009

10) Trospium Chloride 60 mg Extended-release Capsules (Sanctura XR) Para IV filed on March 2, 2009

(Source: USFDA)